BRIEF-Processa Pharmaceuticals To Effect 1-For-25 Reverse Stock Split

Reuters
Dec 16, 2025
BRIEF-Processa Pharmaceuticals To Effect 1-For-25 Reverse Stock Split

Dec 15 (Reuters) - Processa Pharmaceuticals Inc PCSA.O:

  • PROCESSA PHARMACEUTICALS INC - ON DEC 12, FILES CERTIFICATE OF AMENDMENT TO CO'S FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

  • PROCESSA PHARMACEUTICALS INC - TO EFFECT 1-FOR-25 REVERSE STOCK SPLIT - SEC FILING

Source text: [ID:n0001493152-25-027680]

Further company coverage: PCSA.O

((((Reuters.Briefs@thomsonreuters.com));))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10